论文信息 - Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy - 字舞流文

Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy

A. Gonzales | J. Bowman | G. Fici | M. Mitton-Fry | M. Zhang | D. Mann | A. J. Gonzales | M Mitton-Fry | M. Oclacitinib